Table 2 Baseline neuropsychiatric symptoms in patients.
From: Neuropsychiatric symptoms and seizure related with serum cytokine in epilepsy patients
Subject characteristics | Total (n = 129) |
|---|---|
HADS-A ≥ 8—no. (%) | 19 (14.7) |
HADS-D ≥ 8—no. (%) | 18 (14.0) |
NPI-Q severity | 1.0 (0–4.0) |
NPI-Q distress (n = 85) | 1.0 (0–4.0) |
NPI-Q—no. (%) | |
Delusion | 10 (7.8) |
Hallucination | 8 (6.2) |
Agitation/aggression | 17 (13.2) |
Depression/dysphonia | 42 (32.6) |
Anxiety | 13 (10.1) |
Elation/euphoria | 7 (5.4) |
Apathy/indifference | 25 (19.4) |
Disinhibition | 18 (14.0) |
Irritability/lability | 35 (27.1) |
Aberrant motor behavior | 9 (7.0) |
Sleep/night-time behavior | 29 (22.5) |
Appetite/eating disorder | 19 (14.7) |
QOLIE-31 (n = 80) | 32.5 (25.9–42.2) |
Seizure worry | 32.3 (20.0–52.7) |
Overall QOL | 27.5 (16.0–28.5) |
Emotion | 36.0 (12.0–49.0) |
Energy | 55.0 (38.8–70.0) |
Cognition | 21.4 (16.7–35.3) |
Medication | 66.7 (58.3–77.7) |
Social function | 40.0 (35.8–40.0) |
